Author:
Pfeiffer E. F.,Voigt K. H.,Del Pozo E.,Peters F.,Heredia E.,Breckwoldt M.,Schopohl J.,Stalla G. K.,Werder K.,Losa M.,Bock L.,Müller O. A.,Schusdziarra V.,Creutzfeld W.,Usadel K. H.
Reference162 articles.
1. Bai J, Greenwald E, Caterini H, Kaminetzky HA (1974) Drug-related menstrual aberrations. Obstet Gynecol 44: 713–719
2. Bohnet HG, Dahlen HG, Wuttke W, Schneider HPG (1976) Hyperprolectinemic anovulatory syndrome. J Clin Endocrinol Metab 42: 132–143
3. Mendelson JH, Ellingboe J, Kuehnle JC, Mello NK (1980) Heroin and naltrexone effects on pituitary, gonadal hormones in man: Interaction of steroid feedback effects, tolerance and supersensitivity. J Pharmacol Exp Ther 214: 503–506
4. Mirin SM, Meyer RE, Mendelson JH, Ellingboe J (1980) Opiate use and sexual function. Am J Psychiatry 137: 909–915
5. Mendelson JH, Meyer RE, Ellingboe J, Mirin SM, McDougle M (1975) Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther 195: 296–392